What the class literature shows about stopping, and the absence of retatrutide data

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Follow-up of participants after planned cessation of semaglutide in the STEP programme found that a substantial proportion of the lost weight was regained within a year off treatment, with cardiometabolic markers reverting toward baseline. This pattern is consistent with obesity as a chronic condition. Retatrutide has no published cessation follow-up; what happens after stopping it is unknown.

What was studied for the class

Extension studies followed participants after the end of treatment with semaglutide. Over the year after stopping, mean weight rose back substantially from its treated low, and improvements in blood pressure, lipids and glycaemia receded in parallel. Similar patterns have been reported for other agents in the class.

The finding is widely interpreted as showing that the effect depends on continued exposure, as with most treatments for chronic conditions.

What it implies and does not

It implies that trial results describe people on treatment and that the condition is not altered permanently by a period of exposure. It does not imply anything about the mechanism of regain, which is debated, nor about any individual.

It is a class-level observation from specific trials with their own designs and limitations.

Retatrutide

The phase 2 trials ended at 48 and 36 weeks with no off-treatment follow-up reported. There is therefore no published evidence on what happens after retatrutide is stopped. Statements about durability off treatment are extrapolations from the class and should be labelled as such.

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What was studied for the class?

Extension studies followed participants after the end of treatment with semaglutide. Over the year after stopping, mean weight rose back substantially from its treated low, and improvements in blood pressure, lipids and glycaemia receded in parallel. Similar patterns have been reported for other agents in the class.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.